EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023
![EBS stock - EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023](https://investorplace.com/wp-content/uploads/2023/03/ebs1600-768x432.png)
Source: Hanson L / Shutterstock.com
Emergent BioSolutions (NYSE:EBS) just reported results for the third quarter of 2023.
- Emergent BioSolutions reported earnings per share of -87 cents. This was below the analyst estimate for EPS of -22 cents.
- The company reported revenue of $270.50 million.
- This was 13.93% better than the analyst estimate for revenue of $237.43 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/ebs-stock-earnings-emergent-biosolutions-for-q3-of-2023/.
©2023 InvestorPlace Media, LLC